| Financial Year |
March 31 2023 |
| Monetary Funds |
102,081,041.74 |
| Held-for-trading Financial Assets |
575,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
231,005,770.09 |
| Advances to Suppliers |
28,316,089.30 |
| Other Receivables |
37,354,361.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
136,645,985.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,033,267.65 |
| Total Current Assets |
1,145,000,876.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
59,922,301.65 |
| Fixed Assetes |
712,941,533.80 |
| Under-construction Projects |
2,337,589.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,213,043.82 |
| R&D expenses |
-- |
| Goodwill |
2,485,097.93 |
| Long-Term Deferred and Prepaid Expenses |
10,664,371.82 |
| Deferred Income Tax Assets |
6,489,466.14 |
| Other Non-Current Assets |
1,787,622.85 |
| Sub-Total of Non-Current Assets |
913,583,413.76 |
| Total Assets |
2,058,584,290.16 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
105,121,580.72 |
| Accounts Payable |
80,608,106.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,831,973.27 |
| Taxes Payable |
9,502,256.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
37,527,585.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,135,323.25 |
| Other Current Liabilities |
688,692.61 |
| Sub-Total of Current Liabilities |
442,239,906.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
9,047,691.64 |
| Sub-Total of Non-Current Liabilities |
40,830,557.07 |
| Total Liabilities |
483,070,463.76 |
| Paid-In Capital(Or Share Stock) |
545,666,421.00 |
| Capital Surplus |
249,470,994.39 |
| Surplus Reserve |
332,072,731.05 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
441,784,234.91 |
| Minority Stockholder's Interest |
6,519,445.05 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,568,994,381.35 |
| Owner's Equity（Stockholder's Equity） |
1,575,513,826.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,058,584,290.16 |
